What is the new anti-rejection medication? Exploring the Next Generation of Immunosuppressants
•
4 min read
The organ transplant immunosuppressant drug market is projected to grow to $6.61 billion by 2029 [1.3.6]. A key part of this evolution is the development of new anti-rejection medication. So, what is the new anti-rejection medication landscape and how does it improve patient outcomes?
